Cigna reported $282.4B of revenue over the trailing twelve months, +7.8% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $282.4B (to Q2 2026). Net Income: $6.98B, trailing twelve months to Q2 2026. Op Margin: 3.5%, trailing twelve months to Q2 2026. EPS: $24.19, trailing twelve months to Q2 2026.

CICigna

HealthcareUSD

$280.86

$240.3252 weeks$305.80

CI as reported

Cigna reported $282.4B of revenue over the trailing twelve months, +7.8% on the year before. 11 reported series are charted on this page, each one as filed.

$282.4B

Revenue, trailing twelve months · to Q2 2026 · +7.8% against the twelve months before

Net Income: $6.98B
Net Income · +29% year on year · trailing twelve months to Q2 2026
Op Margin: 3.5%
Op Margin · trailing twelve months to Q2 2026
EPS: $24.19
EPS · +32% year on year · trailing twelve months to Q2 2026

Every series Ryufin has for CI, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$282.4B	+7.8%	Q2 2026
Net Income	$6.98B	+29%	Q2 2026
EPS	$24.19	+32%	Q2 2026
Gross Margin	21%	n/a	Q2 2026
Op Margin	3.5%	n/a	Q2 2026
Net Margin	2.5%	n/a	Q2 2026
ROE	16%	n/a	Q2 2026
ROA	4.2%	n/a	Q2 2026
ROIC	11%	n/a	Q2 2026
Free Cash Flow	$8.44B	n/a	Q4 2019 · 26 quarters behind
P/E	11.6	n/a	today